220 related articles for article (PubMed ID: 3095423)
1. Monoclonal antibodies, L-35 and L-36, define novel T cell activation antigens.
Maino VC; Janszen ME
J Immunol; 1986 Nov; 137(10):3093-9. PubMed ID: 3095423
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel differentiation antigen complex recognize by a monoclonal antibody (A-1A5): unique activation-specific molecular forms on stimulated T cells.
Hemler ME; Ware CF; Strominger JL
J Immunol; 1983 Jul; 131(1):334-40. PubMed ID: 6408178
[TBL] [Abstract][Full Text] [Related]
3. Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody.
Fox DA; Hussey RE; Fitzgerald KA; Acuto O; Poole C; Palley L; Daley JF; Schlossman SF; Reinherz EL
J Immunol; 1984 Sep; 133(3):1250-6. PubMed ID: 6205075
[TBL] [Abstract][Full Text] [Related]
4. Rabbit leukocyte surface antigens defined by monoclonal antibodies.
De Smet W; Vaeck M; Smet E; Brys L; Hamers R
Eur J Immunol; 1983 Nov; 13(11):919-28. PubMed ID: 6605862
[TBL] [Abstract][Full Text] [Related]
5. Two surface antigens expressed on proliferating mouse T lymphocytes defined by rat monoclonal antibodies.
Takei F
J Immunol; 1983 Jun; 130(6):2794-7. PubMed ID: 6304191
[TBL] [Abstract][Full Text] [Related]
6. A novel glycoprotein expressed on sheep T and B lymphocytes is involved in a T cell activation pathway.
Hein WR; McClure S; Beya MF; Dudler L; Trnka Z
J Immunol; 1988 May; 140(9):2869-75. PubMed ID: 2834446
[TBL] [Abstract][Full Text] [Related]
7. Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines.
Hemler ME; Sanchez-Madrid F; Flotte TJ; Krensky AM; Burakoff SJ; Bhan AK; Springer TA; Strominger JL
J Immunol; 1984 Jun; 132(6):3011-8. PubMed ID: 6327814
[TBL] [Abstract][Full Text] [Related]
8. A novel differentiation antigen on proliferating murine thymocytes identified by a rat monoclonal antibody.
Takei F
J Immunol; 1984 Feb; 132(2):766-71. PubMed ID: 6418809
[TBL] [Abstract][Full Text] [Related]
9. Variation in the synthesis of membrane proteins of human T lymphocytes during mitogenic activation: recognition of a 70,000 dalton protein with anti-p23,30 heteroantiserum and a novel 42,000 dalton protein with anti-p44,12 heteroantiserum.
Boto WO; Humphreys RE
J Immunol; 1981 Feb; 126(2):759-65. PubMed ID: 6969761
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the human CD27 ligand, a novel member of the TNF gene family.
Hintzen RQ; Lens SM; Beckmann MP; Goodwin RG; Lynch D; van Lier RA
J Immunol; 1994 Feb; 152(4):1762-73. PubMed ID: 8120385
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8.
Kansas GS; Wood GS; Fishwild DM; Engleman EG
J Immunol; 1985 May; 134(5):2995-3002. PubMed ID: 3156924
[TBL] [Abstract][Full Text] [Related]
12. The mitogenic lectin from Phaseolus vulgaris does not recognize the T3 antigen of human T lymphocytes.
Kanellopoulos JM; De Petris S; Leca G; Crumpton MJ
Eur J Immunol; 1985 May; 15(5):479-86. PubMed ID: 3873340
[TBL] [Abstract][Full Text] [Related]
13. A new epitope of the T200 molecule family defined by the 3A35 monoclonal antibody and expressed by macrophages and activated T lymphocytes.
Le Corre R; Gerlier D; Martin A; Le Garrec Y; Corradin G; Bron C; Toujas L
Eur J Immunol; 1987 Mar; 17(3):327-33. PubMed ID: 2436920
[TBL] [Abstract][Full Text] [Related]
14. Expression of Leu-19 (NKH-1) antigen on IL 2-dependent cytotoxic and non-cytotoxic T cell lines.
Lanier LL; Le AM; Ding A; Evans EL; Krensky AM; Clayberger C; Phillips JH
J Immunol; 1987 Apr; 138(7):2019-23. PubMed ID: 2951430
[TBL] [Abstract][Full Text] [Related]
15. Antigen-independent activation of T cells mediated by a novel cell surface heterodimer (Tp135-145).
Isler P; Salvi S; Rapin C; Giuffrè L; Cerottini JC; Carrel S
Eur J Immunol; 1988 Oct; 18(10):1491-8. PubMed ID: 3263919
[TBL] [Abstract][Full Text] [Related]
16. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen.
van Lier RA; Borst J; Vroom TM; Klein H; Van Mourik P; Zeijlemaker WP; Melief CJ
J Immunol; 1987 Sep; 139(5):1589-96. PubMed ID: 2442250
[TBL] [Abstract][Full Text] [Related]
17. Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.
Tsoukas CD; Landgraf B; Bentin J; Valentine M; Lotz M; Vaughan JH; Carson DA
J Immunol; 1985 Sep; 135(3):1719-23. PubMed ID: 3926881
[TBL] [Abstract][Full Text] [Related]
18. Use of the monoclonal antibody 12F1 to characterize the differentiation antigen VLA-2.
Pischel KD; Hemler ME; Huang C; Bluestein HG; Woods VL
J Immunol; 1987 Jan; 138(1):226-33. PubMed ID: 3023488
[TBL] [Abstract][Full Text] [Related]
19. Cell surface molecular changes on the activation of human thymocytes.
Sanchez-Madrid F; Toribio ML; Gambón F; de Landazuri MO
J Immunol; 1985 Dec; 135(6):3938-43. PubMed ID: 2415591
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen.
Lazarovits AI; Moscicki RA; Kurnick JT; Camerini D; Bhan AK; Baird LG; Erikson M; Colvin RB
J Immunol; 1984 Oct; 133(4):1857-62. PubMed ID: 6088627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
